3 Cancer Treatment Stocks to Buy Right Now
For those with cash on the sidelines, the precipitous market drop means there are currently some promising companies at attractive prices. Let's delve into three exciting cancer drug developers worth strong consideration.
One has successfully commercialized its cancer drug and is expanding its pipeline. Another just received accelerated approval from the U.S. Food and Drug Administration (FDA) for its promising new cancer drug. And the third awaits with bated breath the FDA's approval decision for its lead cancer drug.
Image source: Getty Images.
Source Fool.com
